TLS (FUS) and the related gene EWS encode the Nterminal portion of many fusion oncoproteins involved in human sarcomas and leukemia. TLS is an RNA-binding nuclear protein that is identical to hnRNP P2 and may be implicated in mRNA metabolism. When RNA polymerase II is inhibited, TLS immunostaining in the nucleus is dramatically altered, from its normal diuse nucleoplasmic pattern to accumulation in dense nuclease-resistant aggregates. Co-immunostaining with antibodies to ®brillarin or p80 coilin and immunoelectron microscopy revealed that the TLS aggregates are associated with the nucleolus and are distinct from other known structures such as the coiled body or the interchromatin granule. Injection of cells with an oligodeoxynucleotide that disrupts splicing does not result in redistribution of TLS, indicating that the event is speci®c to inhibition of transcription. Oncoproteins that contain the N-terminal domain from either TLS, EWS or their Drosophila homologue, SARFH (CAZ), are also targeted to the same structure. These ®ndings suggest a correlation between the topogenic and transforming activities of TLS and EWS N-termini and imply the existence of cellular targets that are shared by the germ-line encoded proteins and their oncogenic derivatives.
Introduction TLS (also known as FUS) is an RNA binding protein, the N-terminus of which is fused to the transcription factor CHOP in human myxoid liposarcoma (Crozat et al., 1993; Rabbitts et al., 1993) and ERG in acute myeloid leukemia (Ichikawa et al., 1994; Panagopoulos et al., 1994) . TLS is similar in amino-acid sequence to EWS, a nuclear protein that contributes a highly related N-terminal domain to multiple fusion oncoproteins. The C-terminal portion of the EWS-associated oncoproteins is derived from various unrelated transcription factors: FLI1 or ERG (Delattre et al., 1992; Zucman et al., 1993b) , ATF1 (Zucman et al., 1993a) , WT1 (Ladanyi & Gerald, 1994; Rauscher et al., 1994) , TEC (an orphan nuclear receptor Labelle et al., 1995) and CHOP (Panagopoulos et al., 1995) . Cellular transformation by EWS-FLI1 and by TLS-CHOP, prototypical members of this group of fusion oncogenes, is dependent on both the N-terminal sequence contributed by TLS or EWS and on the integrity of the DNA-binding and dimerization domain of FLI1 and CHOP respectively (May et al., 1993; Zinszner et al., 1994) . Deregulation of target genes contacted by the transcription factor component of these chimeras probably plays an important role in the process of transformation (Bailly et al., 1994; Brown et al., 1995; Fujimura et al., 1996; Magnaghi-Jaulin et al., 1996; May et al., 1993; Rauscher et al., 1994; Zinszner et al., 1994) . This mechanism is consistent with the observation that the N-termini of TLS and EWS serve as potent transcriptional activation domains when placed in the proximity of a promoter (Bailly et al., 1994; Brown et al., 1995; Lessnick et al., 1995; May et al., 1993; Zinszner et al., 1994) .
In addition, however, there is evidence to suggest that the N-terminus of TLS and EWS participates in activities other than contacting the transcriptional machinery (transactivation). While in the case of Fli1 fusion proteins, potent transcriptional activation domains can eectively substitute for the TLS/EWS N-terminal domain , fusion of CHOP to potent heterologous transactivation domains does not fully substitute for the transforming activity imparted by the N-terminus of TLS or EWS (Zinszner et al., 1994) . Furthermore, the N-terminus of a Drosophila homologue of TLS and EWS, a protein known as SARFH or CAZ (Immanuel et al., 1995; Stolow and Haynes, 1995) , imparts strong transforming activity when fused to CHOP, even though it does not activate transcription (Immanuel et al., 1995) . It is thus possible that, in addition to their proven eects on genes targeted via the DNA-binding component of the chimera Brown et al., 1995; May et al., 1993) , oncoproteins of this type also impinge in some way on the cellular pathways and contingents of the normal, germline encoded TLS and EWS proteins. This speculation is further supported by the observation that in this group of human oncoproteins it is the functionally-interchangeable TLS and EWS-type Nterminus (and not the DNA-contacting transcription factor) that is invariant. Interference with the normal activity of TLS/EWS could be common to the activity of oncoproteins of this class.
TLS has recently been found to be identical to hnRNP-P2 (Calvio and Lamond, 1995) . This is consistent with our ®ndings that the protein is abundant and continuously shuttles from the nucleus to the cytoplasm in a large complex that contains mRNA and other hnRNPs (Zinszner et al., 1994 and our unpublished observations). In interphase, steady state levels of the protein are highest in the nucleus, where immunostaining reveals a diuse homogenous nucleoplasmic pattern. Treatment of cells with inhibitors of transcription leads to a profound reorganization of many nuclear structures and substantially alters the pattern of TLS staining (Zinszner et al., 1994) . In this study we describe the association of TLS with a novel nucleolar structure that is also contacted by the TLS and EWS N-terminus-containing oncogenic fusion proteins. The implications for the presence of cellular target(s) shared by germline encoded TLS and its derivative oncoproteins are discussed.
Results

TLS accumulates in a novel nuclear structure when transcription is inhibited
In interphase, TLS immunoreactivity is diusely nucleoplasmic and excludes the nucleolus (Figure 1a ). When RNA PolII transcription is inhibited (by treatment with actinomycin D, a-amanitin or 5,6 dichlororibofuranosyl benzimidazole, DRB) a substantial fraction of the TLS redistributes to the cytoplasm. This phenomenon is observed in all cells but is more obvious in some, such as Hela (Zinszner et al., 1994 and Figure 1 ). In cells treated with inhibitors of transcription, extraction with detergent prior to ®xation causes additional loss of the diuse nucleoplasmic signal and reveals the presence of an underlying novel pattern of TLS staining. This latter is characterized by bright aggregates, 1 ± 4 mm in diameter, scattered throughout the nucleus. They vary in number from 1 to 30 and have been identi®ed in all cell types we have studied, including primary nontransformed cells ( Figure 1a ).
Other nuclear proteins are not co-localized with TLS in the aggregates. The abundant hnRNPs A1 and C1/ C2, proteins that normally associate with TLS in a large ribonucleoprotein particle (Calvio and Lamond, 1995; Zinszner et al., 1994 and unpublished data), do not accumulate in similar aggregates (Figure 1b) . The SC-35 splicing factor (Fu & Maniatis, 1990; Spector et al., 1991) accumulates in enlarged interchromatin granules following inhibition of transcription or splicing (Carmeo-Fonseca et al., 1992; O'Keefe et al., 1994 and see below) . Yet the structure de®ned by TLS is distinct from the major site of accumulation of SC-35 ( Figure 1b ). Other nuclear antigens we have tested, such as the transcription factors CREB and C/EBPb also do not co-localize with TLS in actinomycin Dtreated cells (data not shown).
The association between TLS and the novel structure is preserved in cells treated with RNase or DNase, suggesting that it is mediated by a stable protein-protein interaction (Figure 2a ). The diminution of propidium iodide staining of the nucleolus in the RNase treated cells and the similar diminution of the H33258 signal in the DNase treated ones is an indication of the extent of the nuclease digestions.
To determine if redistribution of TLS is related to perturbations of gene expression other than inhibition of transcription, we injected cells with an oligodeoxynucleotide complementary to the U1 snRNA. This oligodeoxynucleotide inhibits splicing and consequently later stages of gene expression and causes redistribution of the splicing factor SC-35 from the perichromatin ®brils to interchromatin granules (O'Keefe et al., 1994) . This is re¯ected in an enlargement of the latter structure and a diminution of the more diuse granular nucleoplasmic staining by SC-35 (Figure 2b , lower panels). Under the same conditions, TLS staining remains unaltered (upper panels). From the results of this experiment we conclude that redistribution of TLS is speci®c to inhibition of RNA polymerase II transcription and is not a feature of cells in which splicing has been inhibited.
The redistribution of TLS following inhibition of transcription could be a passive epi-phenomenon secondary to re-organization of the chromatin or nuclear matrix. In cells treated with DRB (a reversible inhibitor of transcription), the TLS redistribution is reversible upon removal of the inhibitor (Zinszner et al., 1994 and data not shown), suggesting that the pattern we observe is not an end stage artifact. Further evidence that the redistribution of TLS is an active process is provided by a mutant cell line that is defective in many aspects of protein and mRNA transport across the nuclear pores and within the nucleus. The BHK-21 derivative cell line tsBN2 (Nishimoto et al., 1978) has a temperature sensitive defect in mRNA export and other aspects of nuclearcytoplasmic and intranuclear macromolecular transport (Amberg et al., 1993; Cheng et al., 1995) . These defects are due to loss of RCC1 (Nishitani et al., 1991) , a guanine nucleotide exchange factor for the GTPbinding protein Ran/TC4 (Coutavas et al., 1993) . TLS staining in tsBN2 cells growing at the permissive and non-permissive temperature is normal. Redistribution of the protein to the aggregates was readily observed in the mutant cells at the permissive temperature and in the wild-type cells at both the permissive and non-permissive temperature but failed to occur in the mutant cells at the non-permissive temperature (Figure 2c ). RCC1 protein levels fell rapidly in the mutant cells growing at the nonpermissive temperature, an indication that the temperature switch had the expected eect (Figure 2c , lower panel). This experiment suggests that TLS redistribution in response to inhibition of transcription is an active process that requires the integrity of Ran/ TC4-RCC1 apparatus. The experiment does not however permit us to distinguish between redistribution being a primary response to inhibited transcription or a response to a secondary event such as diminished mRNA export.
The novel structure delineated by TLS is associated with the nucleolus Based on its appearance, the structure delineated by TLS in treated cells could be associated with the nucleolus. To explore this possibility further, we costained DRB-treated cells with murine monoclonal antibodies to TLS and human autoimmune sera to ®brillarin (a marker for the ®brillar component of the nucleolus, Ochs et al., 1985) . The selective RNA polymerase II inhibitor DRB was chosen (over actinomycin D) because the former does not signi®cantly alter the pattern of nucleolar staining by ®brillarin. The TLS aggregates in DRB-treated cells can be observed to surround a central core of dense ®brillarin staining, indicating that when transcription is inhibited TLS associates with the nucleolus ( Figure  3a) .
To con®rm that TLS association with the nucleolus is also a feature of actinomycin D treated cells, we costained Hela cells with murine monoclonal antibodies to TLS and rabbit antiserum to p80 coilin. The latter protein has been observed to accumulate in a structure known as the coiled body (for review see, Brasch & Ochs, 1992) . In cells treated with actinomycin D the coiled bodies have been found to associate with the nucleolus (Raska et al., 1990) . The TLS aggregates are often found next to the p80 coilin stained bodies, but careful overlay of the images reveals that the two structures are distinct ( Figure 3b ). This indicates that the TLS-containing structure is associated with the nucleolus but is not a coiled body.
Attempts to clearly visualize the association of TLS with the novel structure in actinomycin D treated cells that had not been extracted with detergent were frustrated by the high level of diuse nucleoplasmic TLS staining. This left open the possibility that the nucleolar aggregates of TLS are an artifact of the detergent extraction procedure, rather than an in vivo phenomenon. Thin section immunoelectron microscopy was used to study the pattern of TLS staining in cells rapidly ®xed in gluteraldehyde, without prior extraction with detergent. As shown in Figure 3c , dense accumulation of TLS immunoreactivity was observed associated with the nucleolus (upper panel). The association between TLS and the nucleolus was also found by immunoelectron microscopy in cells that were extracted with detergent prior to ®xation. As expected, detergent extraction led to signi®cant reduction in the level of nucleoplasmic TLS staining (Figure 3c middle panel). Staining of cells with pre-immune serum reveals that the level of background signal in our analysis is very low (Figure 3c , lower panel). We conclude that association of TLS with the nucleolus is an in vivo phenomenon and not an artifact of detergent extraction.
The N-terminal,`oncogenic' portion of TLS speci®es association with the novel nuclear structure
Having found an association between TLS and the nucleolus, we sought to determine which portion of TLS speci®es this interaction. Epitope-tagged TLS and derivative proteins were expressed in COS1 cells and their association with the novel nuclear structure was compared with that of the endogenous protein ( Figure  4b shows schematically the structure of the proteins). Full length tagged TLS aggregated in a nuclear structure that was indistinguishable in its appearance from that delineated by the endogenous TLS. In the transfected cells it is impossible to discriminate between the contribution of the endogenous and transfected protein to the TLS staining, so the comparison must be made to the adjacent non-transfected cells (Figure 4a) . A truncated form of TLS consisting of the epitope-tagged N-terminus of the protein also associated with the novel structure ( Figure 4a , middle panels). In this experiment the endogenous TLS is revealed with an antibody that recognizes the C-terminus (the portion missing in the transfected protein), allowing simultaneous detection of the transfected and endogenous protein. The increase in number of aggregates in the N-terminal TLS-containing cells over that found in normal cells is a reproducible ®nding the cause of which is not known. The C-terminus of TLS does not accumulate in the nucleus (data not shown), therefore a nuclear localization signal from the SV40 large T antigen was added to the tagged C-terminal expression construct. This C-terminal TLS fragment is functionally intact in so much as it is capable of binding RNA in vivo (YY, data not shown). However, in spite of accumulation to high level in the nuclei of transfected cells, this protein is not co-localized with the endogenous TLS in the characteristic aggregates (Figure 4a, lower panels) . From this analysis we conclude that the N-terminal portion of TLS, the one fused to other transcription factors in human oncoproteins, is responsible for directing the protein to nucleolar aggregates in cells treated with transcriptional inhibitors.
N-terminal TLS-containing oncoproteins associate with the novel structure
Having identi®ed the N-terminal,`oncogenic', portion of TLS as playing a role in the protein's association (Crozat et al., 1993) . Under normal conditions CHOP and TLS have indistinguishable diuse nucleoplasmic patterns of staining (Crozat et al., 1993 and Figure 5a ). When transcription is inhibited both antigens accumulate in the novel nucleolar structure. In this experiment the germlineencoded TLS is stained with a mouse monoclonal antibody that detects the C-terminal portion (missing from TLS-CHOP) and TLS-CHOP is stained with rabbit polyclonal serum to CHOP. Endogenous CHOP is not expressed in these cells, therefore, the CHOP antiserum is detecting only TLS-CHOP (Crozat et al., 1993) . The possibility that colocalization of the signals is due to cross reactivity of the secondary antibodies or a contamination between the emission of the¯uorochromes used to detect the two antigens has been rigorously excluded by viewing images of cells stained with only one antibody or only one¯uorochrome (data not shown).
In a previous study this co-localization had been 
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(a) COS cells transiently expressing Myc epitope-tagged wild-type TLS (9E10-TLS), the N-terminus (9E10-N-term TLS) or the C-terminus (9E10-C-term TLS)
were treated with actinomycin D and immunostained with rabbit polyclonal serum to the N-terminus of TLS (left panels) and a monoclonal antibody to the Myc epitope tag (9E10, right panels). The wild-type and N-terminal fragment of TLS are present in typical focal aggregations whereas the C-terminal fragment is present in a diuse nucleoplasmic pattern. (b) Schematic structure of the proteins used in this experiment and in that described in Figure 5a . NLS refers to the nuclear localization signal that had been attached to the 9E10-C-term TLS protein and RRM refers to the RNA recognition motif missed because the cells had not been extracted with detergent prior to ®xation (Zinszner et al., 1994 , (Zinsner et al., 1994 . Peptide sequences that functionally substitute for the N-terminus of TLS in producing oncogenic proteins when fused with CHOP have been previously de®ned (Immanuel et al., 1995; Panagopoulos et al., 1995; Zinszner et al., 1994) . We compared the staining pattern of oncogenic CHOP fusion proteins with similar non-transforming derivatives. TLS-CHOP, EWS-CHOP and D12-type splice variant of SARFH-CHOP, all of which are transforming, were found localized at the nucleolar region when transcription was inhibited, whereas CHOP and the non-transforming fusion between the activation domain of C/EBPa and CHOP were not (Figure 5b ). The weaklytransforming fusion between the D5-type splicing variant of SARFH and CHOP did not, for the most part associate with the structure (Figure 5b ) although occasionally cells could be seen with weak nucleolar staining of D5-SARFH-CHOP (less than 5%). The nucleolar localization of EWS-CHOP is entirely consistent with the high degree of similarity between TLS and EWS. Indeed, using antiserum raised in rabbit against the N-terminus of EWS we have visualized the endogenous EWS protein associated with the same structure (not shown). These experiments point to a correlation between nucleolar localization and transforming capability.
Discussion
In this study, a novel feature common to TLS and its derivative oncogenic fusion proteins is revealed: the association of these antigens with the nucleolar region when transcription is inhibited. This is a highly reproducible ®nding observed in all mammalian celltypes examined, including non-transformed primary cells in culture. Several lines of evidence lead us to conclude that the immunohistochemical ®ndings re¯ect the in vivo distribution of the proteins and are not the result of staining or post-®xation artifacts. The possibility that antibodies against TLS react with an unrelated nucleolar antigen that is fortuitously unmasked when transcription is inhibited is unlikely because similar staining is seen with antibodies raised against two distinct non-overlapping domains of TLS including a panel of monoclonal antibodies reactive against dierent epitopes in the C-terminal portion of the molecule. The possibility that the association of TLS with the nucleolus is an in vitro artifact of the detergent extraction procedure used to reduce the nucleoplasmic TLS stain is virtually excluded by the immunoelectron micrographs of cells that had not been extracted prior to ®xation. Furthermore, co-staining of cells with a host of antibodies directed against other proteins failed to reveal a similar pattern, attesting to its speci®city for TLS.
In analysing the signi®cance of this ®nding it is convenient to consider separately the normal, germline encoded, TLS and the derivative fusion oncoproteins. When RNA Polymerase II transcription or splicing are inhibited, splicing factors and snRNPs relocate from the perichromatin ®brils and coiled bodies to the interchromatin granules (Carmeo-Fonseca et al., 1992; O' Keefe et al., 1994) . The signi®cance of this ®nding is not completely understood but it is believed that the interchromatin granule serves as a repository for storage and/or assembly of splicing factors. When transcription, or splicing are inhibited, the recruitment of these factors from the interchromatin granules to the sites of active transcription is blocked. Thus their retention in the interchromatin granules can be viewed as a default event (reviewed in Mattaj, 1994) . By analogy it is possible that association between TLS and the nucleolar region represents the retention of TLS in what is normally a transient subnuclear compartment. The association between TLS and the nucleolus, if it occurs normally, must be transient because TLS is not normally observed in the nucleolar region (Figure 1) .
Recent experiments have suggested a link between the nucleolus and the processing of some RNA polymerase II transcripts: A subset of transcripts encoding mammalian (c-myc, N-myc and myoD, Bond and Wold, 1993 ) and viral genes (Harders et , 1989; Kalland et al., 1991) have been localized to the nucleolus in several cell types. In addition the HTLV-1 protein Rex, that directs the cytoplasmic export of incompletely spliced viral mRNAs, has also been shown to localize to the nucleolus (Siomi et al., 1988) , where its presence is linked to the processing event (Kalland et al., 1991) . The association between the coiled body, a structure that may normally function in transcription and splicing (CarmeoFonseca et al., 1992) , and the nucleolus (Bohmann et al., 1995; Raska et al., 1990) lends further support to this link. Finally, in ®ssion yeast, Poly(A) + mRNA accumulates in the nucleolus when gene expression is perturbed by heat shock or by a temperature sensitive mutation in the RCC1 gene homologue pim1, necessary for export of Poly(A) + RNA from the nucleus (Tani et al., 1995) . We propose that the mRNA-binding protein TLS participates in an aspect of mRNA metabolism that operates with a nucleolar node; by inhibiting transcription this association is revealed as an accumulation of TLS at that site. A similar speculation has been raised by Lee et al. (1996) based on the observation that the yeast hnRNP-like protein Np13p accumulates in the nucleolus when Po1II transcription is inhibited. The parallels between Np13 and TLS extend to fact that both are RNA binding proteins that shuttle from the nucleus to the cytoplasm. Additional supportive evidence for this speculation comes from an analysis of the tsBN2 cells that have a temperature sensitive defect in RCC1, a GTP exchange factor for Ran/TC4, a molecule that is implicated in multiple aspects of nuclear transport (Cheng et al., 1995; Moore and Blobel, 1993) . At the non-permissive temperature tsBN2 cells are defective in some aspects of nucleolar transport, for example newly synthesized U3 snRNA does not accumulate in the nucleolus (Cheng et al., 1995) . At the same time these cells are defective in TLS association with the nucleolus, suggesting that the latter process is an active one that depends on the Ran/TC4 transport cycle.
It is possible that TLS does not normally associate with the nucleolus but accumulates there when transcription is inhibited as a consequence of interaction with another entity that is primarily recruited to that site. The identity of the N-terminal TLS target(s) is not known. However, the fact that the association between TLS and the nucleolus is not disrupted by RNase or DNase treatment, suggests that it is a protein. Furthermore, the fact that TLS-CHOP, which does not bind RNA, is also recruited to the nucleolus renders it unlikely that targeting occurs via associations that depend on mRNA/pre-mRNA binding. An alternative explanation, in which recruitment of TLS to the nucleolar region is a consequence in a primary perturbation in nucleolar function related to alterations in RNA Polymerase I gene transcription is not favored because selective inhibition of RNA Polymerase II is also associated with TLS re-localization. However it is impossible to exclude that inhibited PolII transcription indirectly alters nucleolar function and recruitment of TLS proceeds as secondary event. Finally, it is possible that when transcription is inhibited, the perturbation causing TLS association with the nucleolus is brought about by falling levels of a labile protein. The likelihood of this scenario is however minimized by our observation that inhibition of protein synthesis by cycloheximide does not lead to association of TLS with the nucleolus (data not shown).
TLS (and perhaps EWS) are so far unique among the hnRNPs in their association with the nucleolar region ± other proteins such as the splicing factors U1 snRNP and U2AF distribute to that region of the nucleus when transcription is inhibited (CarmeoFonseca et al., 1992) . hnRNP A1 and C1/C2, that form a complex with TLS in vivo (Zinszner et al., 1994) do not associate with the novel structure. This suggests that the plurality of hnRNPs is actually composed of functionally distinct subsets of proteins. It is intriguing to consider the possibility that by virtue of sequencespeci®c RNA-binding properties TLS may direct a subset of pre-mRNA/mRNAs to a path that normally involves the nucleolar region. This speculation is consistent with the fact that in situ histohybridization reveals only a discrete subset of mRNA to be associated with the nucleolus (Bond and Wold, 1993) .
How do these ®ndings shed light on the process of transformation by TLS fusion proteins? As a minimum, we may accept that association with the nucleolus is a marker for the presence of a nuclear target(s) that interacts with the N-terminus of TLS and is shared by the oncogenic derivative fusion proteins (TLS-CHOP) but not by the germ-line encoded transcription factor (CHOP). It is thus possible that contacting this target perturbs some aspect of the normal function of the transcription factor component of the chimeric oncoprotein. This mechanism contributes to transformation by deregulating the expression of transcription factor target genes. Alternatively, the association of TLS N-terminal containing fusion oncoproteins, that lack the normal RNA-binding domain, with the target(s) may disrupt some aspect of TLS function. This latter mechanism could operate in parallel with deregulation of transcription factor targets and is attractive because it may represent a mechanism common to the many oncogenes that contain a TLS/EWS-type N-terminus.
Materials and methods
Cell culture, treatment and ®xation
Hela, COS1 and NIH3T3 cells were obtained from ATCC. The human myxoid-liposarcoma cell line 1955/91 has been described previously (Crozat et al., 1993) . The temperature sensitive mutant line tsBN2 and wild-type BHK 21 cells were a gift of Dr Mark Rush (NYU). Primary human foreskin ®broblasts were a gift of Dr Jan Vilcek (NYU). All cells were cultured in DMEM with 10% fetal calf serum. For immunohistochemistry, cells were cultured on Fisherband 12 mm circular glass coverslips (Fisher Scienti®c, Pittsburgh, PA). Cells were treated with actinomycin D (Boehringer Mannheim, Indianapolis, IN) 5 mg/ml, or 5,6 dichlororibofuranosyl benzimidazole (DRB, Sigma, St Louis, MO) 100 mM for 3 h. Pre-®xation extraction with detergent was performed essentially as described (Fey et al., 1986; Lenk et al., 1977) . Brie¯y, cells were washed in ice-cold phosphate-buered saline (PBS) and placed on ice in ceramic wells containing CSK buer (10 mM Pipes pH=6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 0.5 mM PMSF) with 0.5% Triton X-100 for 1 min. The coverslips were then washed brie¯y with PBS and ®xed at room temperature for 15' in PBS with 4% formaldehyde (Methanol free, ultra pure grade from Polysciences Inc., Warrington PA) followed by further permeabilization with 0.2% Triton X-100 for 5 min. Nuclease treatment of such permeabilized cells was performed as previously described (Spector et al., 1991) .
Antibodies and immunostaining
The rabbit polyclonal antiserum to the N-terminus of TLS (amino-acids 78 ± 244) and to CHOP have been previously described (Crozat et al., 1993; Ron and Habener, 1992; Zinszner et al., 1994) . They were used at a dilution of 1 : 1000 in immunocytochemistry. Murine monoclonal antibodies to the C-terminus of TLS were produced by immunizing FVB/N and AJ/HeJ mice against a bacteriallyexpressed glutathione S-transferase fusion protein containing TLS residues 275 ± 527. Splenocytes were fused to Balb/ c-derived P3X63-AG8.653 myeloma cells and hybridomas were screened by reactivity to the C-terminus of TLS (expressed in bacteria without the GST-tag). Speci®city of the hybridomas was analysed by Western immunoblotting and immunoprecipitation of 35 S-labeled proteins. Supernatants from the hybridomas 4H11, 10A6, 1G10 and 4B11 that react speci®cally with TLS (no EWS reactivity) gave indistinguishable patterns of TLS staining and were used as a pool at a dilution of 1:15 to detect TLS by immunocytochemistry. The hybridoma reactive with the myc epitope tag 9E10 (Evan et al., 1985) was purchased from ATCC. Monoclonal antibodies to hnRNP A1 (4B10) and C1/C2 (4F4), anti SC-35, human antiserum to ®brillarin and rabbit serum to p80 coilin were the gracious gifts of Drs G Dreyfuss (University of Pennsylvania), X-D Fu (UCSD) and R Ochs (Scripps Institute) respectively. Fluoroscein and Texas-red conjugated anity puri®ed cross-adsorbed donkey anti-mouse and donkey anti-rabbit IgG were purchased from Chemicon Temecula, CA and used at a dilution of 1 : 100.
Fixed cells were incubated with the primary antibodies diluted in PBS with 0.05% Tween 20 for 1 h at room temperature, rinsed ®ve times in same buer and incubated for 30' with¯uorochrome-conjugated secondary antibodies, washed and mounted in a glycerol-based mounting media and visualized using a Zeiss Axiophot microscope with epiuorescence illumination and #10 ®lter sets for¯uoroscein and #00 for Texas-red. Images were photographed using Kodak Ektachrome elite 400 ASA slide ®lm. Slides were scanned with a Nikon scanner and digitized images processed using Adobe Photoshop software package.
Plasmid transfections and micro injection
The plasmids encoding CHOP (Ron and Habener, 1992) , the TLS-CHOP, EWS-CHOP, C/EBPa-CHOP (Zinszner et al., 1994) , and SARFH-CHOP (Immanuel et al., 1995) have all been previously described. The myc epitope tagged Nterminal TLS expression plasmid was produced by ®rst ligating the BamHI-PvuII fragment from 9E10-CHOP into BamHI-EcoRV digested pCDNA1 (Invitrogen, La Jolla, CA) and then transferring the Klenow-repaired BamHIBspHI fragment of human TLS into the repaired NotI site of the derivative plasmid. To create the myc epitope tagged Cterminal TLS expression plasmid, an oligonucleotide encoding the large T-antigen nuclear localization sequence (KKKRKVLA) was inserted between the NotI and XhoI site of 9E10-tagged pCDNAI derivative described above. Then a SalI site was introduced at nucleotide 709 (amino acid 211) of the human TLS cDNA and the fragment ligated into the XhoI-Xba digested plasmid. The encoded protein therefore is tagged with the 9E10 epitope tag followed by a nuclear localization signal. Integrity of the proteins was ascertained by Western blot of transfected COS1 cells. COS cell transfection and Hela cell micro injections were done exactly as previously described (Immanuel et al., 1995; Ron and Habener, 1992) . Micro injection of an oligodeoxynucleotide corresponding to the U1 snRNA into the cytoplasm of Hela cells was performed exactly as described by O'Keefe et al. (1994) . Lysine-tagged Texas red-conjugated 70 Kd dextran particles were used as the injection marker. Cells were ®xed and stained 4 h after micro injection.
Immunoelectron microscopy was performed essentially as previously described (Roth, 1986; Roth et al., 1990) . Brie¯y, Hela cells growing in plastic dishes were extracted with detergent as described above (or left unextracted), brie¯y ®xed (1') with 3% paraformaldehyde, 0.1% gluteraldehyde in a buer containing 4% sucrose and 0.1 M sodium cacodylate and scraped o the plate with a rubber policeman. The cells were pelleted in a microfuge and ®xed extensively for 4 h at 48C in the same and washed in the same buer containing 0.1 M glycine without ®xatives. Following serial dehydration in methanol the cellular pellet was transferred to LK4M mounting media (Polysciences, Inc. Warrington, PA) and embedded by u.v. cross-linking in a gelatin capsule. Ultrathin sections were mounted on carbon-coated nickel grids. After blocking with 1% BSA, 0.05% Triton X-100 in 0.01 M phosphate buer pH=7.4 for 5 min at room temperature post-embeddment immunostaining with rabbit antiserum to TLS, or pre-immune serum was performed at a dilution of 1 : 100 in the same buer for 2 h at room temperature. Following successive jet washes with the same buer the 15 nm gold-particle conjugated anity puri®ed anti-rabbit antibodies were added and further incubated for 1 h at room temperature. After washing the secondary antibody with the same buer the samples were air-dried, stained successively with 3% uranyl acetate (4') and lead acetate (30') and viewed with a JOEl 100 CX electron microscope.
